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Co-registration of glucose metabolism with
positron emission tomography and vascularity
with fluorescent diffuse optical tomography in
mouse tumors
Xiao Tong1,2, Anikitos Garofalakis1,2, Albertine Dubois1,2, Raphaël Boisgard1,2, Frédéric Ducongé1,2,
Régine Trébossen1 and Bertrand Tavitian1,2*
Abstract
Background: Bimodal molecular imaging with fluorescence diffuse optical tomography (fDOT) and positron
emission tomography (PET) has the capacity to provide multiple molecular information of mouse tumors. The
objective of the present study is to co-register fDOT and PET molecular images of tumors in mice automatically.
Methods: The coordinates of bimodal fiducial markers (FM) in regions of detection were automatically detected in
planar optical images (x, y positions) in laser pattern optical surface images (z position) and in 3-D PET images. A
transformation matrix was calculated from the coordinates of the FM in fDOT and in PET and applied in order to
co-register images of mice bearing neuroendocrine tumors.
Results: The method yielded accurate non-supervised co-registration of fDOT and PET images. The mean fiducial
registration error was smaller than the respective voxel sizes for both modalities, allowing comparison of the
distribution of contrast agents from both modalities in mice. Combined imaging depicting tumor metabolism with
PET-[18 F]2-deoxy-2-fluoro-D-glucose and blood pool with fDOT demonstrated partial overlap of the two signals.
Conclusions: This automatic method for co-registration of fDOT with PET and other modalities is efficient, simple
and rapid, opening up multiplexing capacities for experimental in vivo molecular imaging.
Keywords: Co-registration, fDOT, PET, Fiducial marker detection, Optical surface image, Neuroendocrine tumors,
MEN2A
Background
The complexity of tumors and their sophisticated interac-
tions with their environment call for imaging methods
capable of detecting a diversity of tumor hallmarks [1,2].
Positron emission tomography (PET) with [18F]2-deoxy-
2-fluoro-D-glucose (FDG), the most efficient imaging
method to detect cancer, is an indicator of tumor energy
metabolism dominated by aerobic glycolysis in both can-
cer and tumor-associated inflammatory cells [3]. However,
FDG-PET carries no information about other cancer hall-
marks such as angiogenesis, replicative immortality, eva-
sion of growth suppressors, capacity to metastasize, and
yields at best indirect information on resistance to apop-
tosis and proliferation [1]. PET imaging with other radio-
tracers can complement FDG but cannot be performed in
the same imaging session. It also increases radiation ex-
posure. As far as experimental molecular imaging is con-
cerned, multiple PET sessions are difficult to envision on a
large scale because of high cost and low practicability.
Recent progress in fluorescence diffuse optical tomog-
raphy (fDOT) has made 3-D optical molecular imaging of
live animals a reality [4-9]. In contrast to imaging modal-
ities demanding heavy instrumentation such as PET,
fDOT is based on relatively simple hardware that does not
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require a sophisticated technological environment or tedi-
ous safety precautions. fDOT offers nano-molar sensitivity
[5], long follow-up times (days) and is relatively low cost,
and opens in vivo molecular imaging to a huge portfolio
of fluorescent probes and beacons [5,6,8,10]. We [5] and
others [8] have proposed the combination of PET-FDG
and fDOT as a method of choice to provide multiple mo-
lecular data on experimental tumors in mice.
Given the small size (50–500 mm3) of tumors in mice
and the resolution of small-animal PET and fDOT scan-
ners (1–2 mm), accurate and reliable co-registration
between both modalities is essential. Among different co-
registration methods that have been developed, such as
geometrical co-calibration [11] and dynamic contrast
methods [12], the use of fiducial markers (FM) [8] in close
position to the body of the animal is the most straightfor-
ward and universal approach today. The coordinates of
the FM in images acquired independently is used for the
geometrical transformations leading to the fusion of
images. Co-registration of large data sets from different
imaging modalities results in time-consuming, tedious and
operator-dependant image analyses when performed
manually. Therefore, methods for the automatic identifica-
tion of the FM's coordinates have been developed for
co-registration of computed tomography (CT), PET and
magnetic resonance imaging (MRI) modalities [13-18].
However, so far, these methods have not been adapted to
co-registration with fDOT because fDOT reconstruc-
tions are spatially restricted and do not cover the FM
positioning.
Here, we introduce the use of surface images obtained
during the fDOT acquisition session for the automatic
identification of the FM's positions in space. Surface recon-
struction by laser patterning [19] can retrieve the 3-D sur-
face of the subject and of the FM in close vicinity. Surface
reconstruction is directly implemented into the 3-D fDOT-
PET combined image. We show that this method efficiently
performs co-registration of fDOT and PET images of the
same mouse with a co-registration error (fiducial registra-
tion error, FRE) smaller than the intrinsic resolution of PET
and fDOT. This new automatic method facilitates the ac-
curate co-registration of fDOT with PET and other imaging
modalities. As a proof of concept, we imaged mice bearing
neuroendocrine tumors for glycolytic metabolism with
FDG-PET and for tumoral blood pool with a fluorescent
blood pool contrast agent. We show that these two tumoral
hallmarks occupy partially overlapping volumes, suggesting
that the tumor-induced induction of blood supply could be
spatially restricted to a portion of the tumor mass.
Materials and methods
Plexiglas cubes containing FM
The FM were composed of four sources of germanium-
68 (74 kBq; diameter, 1 mm; and length, 0.5 mm; Isotop
Product Laboratories, Valencia, CA, USA) originally
designed for PET-CT co-registration, included in the
center of four Plexiglas cubes of 1 × 1 × 1 cm. A spot
of 2 mm diameter was drawn with standard white li-
quid corrector (Tipp-ExW, Bic, Clichy, France) on top
of each Plexiglas cube, exactly above the 68Ge sources.
The cubes were then glued permanently to a custom
made transparent Plexiglas mouse supporting plate at
four corners close to the position of the mouse on the
plate (Figure 1A).
Animal experiments
Animal experiments were performed under an animal
use and care protocol approved by the animal ethics
committee and conducted in accordance with Directive
2010/63/EU of the European Parliament. Six female
nude mice (body weight of approximately 25 g) were
obtained from Elevage Janvier (Le Genest Saint Isle,
France) and received a subcutaneous injection in the
flank of 106 PC12-multiple endocrine neoplasis syn-
drome type 2A (MEN2A) cells [20]. The mice were
anesthetized by continuous gaseous anesthesia (1–2%
isoflurane in O2) and imaged sequentially by fDOT and
PET. The near-infrared (NIR) fluorescent dye SentidyeW
(20 nmol; Fluoptics, Grenoble, France) was injected 3 h
before starting the fDOT acquisition at a volume of 100 μL.
FDG (7,400 kBq in 100 μL; Flucis, IBA, France) was admi-
nistered 1 h before the PET scan. Each mouse underwent a
20-min fDOT acquisition followed by a 30-min PET acqui-
sition. The anesthetized mice were transferred from the
fDOT to PET scanner by means of the mouse supporting
plate, while great care was taken to avoid movement of the
animal in regard to its support. The contact of the ventral
side of a nude mouse with the Plexiglas surface of the
mouse holder is sticky enough to ensure that the mouse is
not moving when transferred between scanners located at
the same room.
Acquisition of the optical images
Images were acquired in the 3-D optical imager
TomoFluo3-D (Cyberstar, Grenoble, France) [7]. To ob-
tain the position of the FM, two optical images covering
both the subject and the FM were acquired with the
mouse placed in prone position: (1) a planar white light
image recorded from a camera snapshot yielding the x
and y coordinates (Figure 1B), and (2) an image of the 3-D
surface of the animal, acquired by rapid consecutive cam-
era shootings during axial scanning with an inclined green
planar laser of the TomoFluo3-D, yielding the z coordi-
nates (Figure 1C). One image was recorded for each laser
position during laser scanning of the animal in the axial
direction, and all images were then combined into a single
image [7]. A surface image of the animal was then recon-
structed from the intersection curve between the surface


















Figure 1 Outline of the automatic co-registration method for optical and micro-PET images. (A) View of the multimodality mouse support
system showing the four Plexiglas cubes containing the fiducial markers (FM). (B) Planar white light image of the subject used for the extraction
of the planar coordinates of the FM. (C) Optical surface image used for the extraction of the z (vertical) coordinates of the FM (z0opt). (D) A stack
of coronal PET slices that correspond to the different z positions. (E) Projection image of the PET volume signal. The localization of the FM where
their coordinates correspond to the radiation signal (xPET, yPET, zPET) is highlighted by dotted yellow rectangles. (F) Bird's eye view of the optical
image of the mouse. (G) Bird's eye view of the micro-PET volume image. (H) Assembled image of the co-registered optical 3-D PET images. The
image shows the coronal view of the animal with signals from both modalities, while the sagittal view depicts only the PET signal. Four zoom
images of the co-registered FM are shown at the four corners of the image.
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of the animal and the surface of the supporting plate by
triangulation [7].
The fDOT image was obtained by a 20-min scan of
a defined volume of interest covering the tumor using
excitation by a 680-nm laser on the anterior side of
the animal [7] and recording with a CCD camera
fixed above its dorsal side. The scanning grid con-
sisted of 7 × 6 sources in steps of 2 mm, and the
detection area was 15 × 13 mm2. A 2 × 2 binning was
applied, and the mesh volume corresponding to the
detection area was mathematically discretized in voxels of
0.67×0.67×1 mm3 size to build the reconstruction mesh
volume. Finally, the inverse problem of the tomographic
reconstruction was solved with the algebraic reconstruc-
tion technique [7].
PET image acquisition
A 30-min scan was acquired in a Focus 220 Micro-
PET scanner (Siemens, Knoxville, TN, USA). Image
acquisition and reconstruction used the MicroPET
Manager Software (Siemens-Concorde Microsystems)
based on a filtered back-projection algorithm. The at-
tenuation correction was based on the segmentation
of the emission map [21]; the dimensions of recon-
struction volumes were 256 × 256 × 95 with a voxel
size of 0.475 × 0.475 × 0.796 mm3. The counts were
decay-corrected and expressed in Bq/cm3.
Image co-registration
As the three optical images (white light image, surface
image and fDOT reconstruction) were acquired in the
same spatial referential, the transformation matrix be-
tween the fDOT image and the white light image
TfDOT−photo is calculated using the intrinsic parameters
of fDOT. Hence, the TfDOT-PET transformation matrix
for fDOT to PET co-registration is a product of TfDOT-photo
and Tphoto-PET:
TfDOTPET ¼ TfDOTphoto  TphotoPET ð1Þ
The co-registration (Tphoto-PET) method was processed in
four steps:
1. Detection of the optical planar (x, y) FM
coordinates.
The Tipp-ExW spot drawn on the top of each Plexiglas
cube helped visualize the planar position of the FM in
optical images. Four square-shaped regions of
detection (ROD) were assigned onto predetermined
positions in the planar white light image (Figure 1B).
Each ROD had a size of 6 × 6 mm, corresponding to
30× 30 pixels in the concatenated mouse photograph,
i.e., three times larger than the Tipp-ExW spots'
dimensions in order to obey the Nyquist-Shannon
sampling theorem [22] while avoiding parasite signals
from the mouse body. The first step consisted in the
automatic detection of the x and y coordinates of the
FM based on the maximal intensity inside the
corresponding RODs (Figure 1B). Three image
preprocessing steps were then performed successively:
(1) filtering with a 3 × 3 median filter that eliminated
most of the noise present in the RODs, (2) high-pass
thresholding of image pixel intensities at a threshold
value of 90 % of the maximum intensity and (3)
application of a Deriche's recursive Gaussian filter [23]
in order to center the gradient intensity change in the
images of the Tipp-ExW spots. Following these three
steps, the coordinates of the local maximum intensity
in each ROD coincided with the center of the FM
signal given by the Tipp-ExW spots in the planar
white light image and assigned positions (xopt, yopt) of
the FM.
2. Detection of the optical altitude (z) FM coordinates.
Since the optical surface image (Figure 1C) and the
planar white light image are concatenated in the
same orientation and the same pixel size, the (x, y)
coordinates in both images correspond directly. The
intensity values of the optical surface image
representing the distance between the upper surface
of the FM and the supporting plate were measured
at position xopt, yopt to yield the z0opt value of the
upper surface of the FM. Altogether, the
combination of the optical surface image and the
planar white light image allowed assigning full 3-D
coordinates (xopt, yopt, z0opt) to each FM in the
optical image.
3. Detection of PET FM coordinates.
Four 3-D RODs of 9 mm3 (dimensions three times
larger than the dimension of FM signal in PET
image) were defined in the PET volume image
(Figure 1E). Following completion of the same image
preprocessing steps as for the detection of the
optical planar coordinates, the local maximum was
detected in each ROD to yield the coordinates
(xPET, yPET, zPET) of the FM in the PET volume
image. Since the optical and PET signals from the
FM do not coincide in the z dimension (i.e., the
optical signal is on top of the Plexiglas cube, and the
PET signal inserted inside the cube), a distance dz was
added to account for translation in the z direction after
the calculation of the rigid transformation matrix
between the optical and PET image.
4. Transformation from the mouse photograph to the
PET volume.
A rigid transformation with translation and rotation
was applied to co-register the optical and PET
coordinates of the FM. With Po= {Po1, Po2, Po3, Po4}
and Pp= {Pp1, Pp2, Pp3, Pp4} being the four FM
positions in the optical and the PET volume images,
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respectively, the translation T and rotation R were
defined as Equation 2:
Pp ¼ R∗Poþ T ð2Þ
The algorithm to compute the transformation [R,T] used
the singular value decomposition (SVD) [24] approach to






Ppi RPoiþ Tð Þj jj j2; where N ¼ 4 is the number of FM:ð Þ
ð3Þ
The point sets {Ppi} and {Poi} were imposed the same
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Transformation was expressed as Equation 6:
T^ ¼ Pp  R^ Po ð6Þ
The [ R^ , T^ ] is the optimal transformation that maps
the set {Ppi} to the {Poi}. Equation 5, also known as the
orthogonal Procrustes problem [24,25], is minimal when
the last term is maximal.
The optical images, being proportionally larger than the
PET image due (1) to the difference in the pixel size be-
tween the optical planar image (0.21 × 0.21 mm) and the
PET image (0.47 × 0.47 mm), and (2) to the parallax
induced by the camera detecting the Tipp-ExW spots from
the upper surface of the cube, a scaling factor was applied
by calculating the average distance of the points in the x
and y axes between the two modalities as (dox, doy) and
(dpx, dpy):
dox ¼ Po2 xð Þ  Po1 xð Þð Þ þ Po4 xð Þ  Po3 xð Þð Þ½ =2
dpx ¼ Pp2 xð Þ  Pp1 xð Þð Þ þ Pp4 xð Þ  Pp3 xð Þð Þ½ =2
doy ¼ Po3 yð Þ  Po1 yð Þð Þ þ Po4 yð Þ  Po2 yð Þð Þ½ =2
dpx ¼ Pp3 xð Þ  Pp1 xð Þð Þ þ Pp4 xð Þ  Pp2 xð Þð Þ½ =2
ð7Þ









where Sx ¼ doxdpx , Sy ¼
doy
dpy
and S z= 1 (i.e., no scaling in
the z direction).
After correcting for distance dz, the final transform-
ation matrix Tphoto-PET for the optical photograph to the
PET volume was:
TphotoPET ¼
R^S11 R^S12 R^S13 T^ x
R^S21 R^S22 R^S23 T^ y





where RS are the rotation matrix elements R multiplied
by the scaling matrix elements S of Equation 8.
Applying the matrix in Equation 9 to the optical pho-
tography (Figure 1F) aligned the 3-D PET image (Figure
1G) to yield the co-registered bimodal image shown in
Figure 1H.
The barycenter-based method
The barycenter-based method [13-18] calculates average
location of body's mass weighted in space. The barycen-
ter was calculated as the center of mass B of a system (i.
e., all voxels within the RODs) defined as the average of






For the mouse photograph, as the barycenter was calcu-
lated in two dimensions, the left upper corner of each
ROD was taken as origin, and the vector ri corresponded
to the relative position from this origin to each pixel
within the ROD. The signal intensity of each pixel inside
the ROD gave the value of mi. For the PET image, the
barycenter was calculated in 3-D, and the position of the
first voxel (left upper in coronal view and first section in
the z direction) of the 3-D ROD was taken as the origin.
The position of each voxel relative to this point was
taken as ri and the value of each voxel as mi. The bary-




The general outline of the co-registration method is
depicted schematically in Figure 1. Five steps are imple-
mented successively: (1) registration of (xopt, yopt, z0opt),
i.e., the x, y and z coordinates of the optical FM using
both the white light (Figure 1 B) and optical surface
(Figure 1C) images; (2) calculation of TfDOT-photo, the
transformation matrix from the fDOT reconstruction
image to the whole body image; (3) registration of (xPET,
yPET, zPET), i.e., the x, y and z coordinates of the FM in
the PET images (Figure 1D,E); (4) calculation of Tphoto-
PET, the transformation matrix from optical to PET
volumes (Figure 1H); and (5) calculation of TfDOT-PET,
the transformation matrix for the co-registration of the
fDOT volumes with the PET volumes.
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The complete image processing method was written in
C++ and integrated in Python with a user-friendly inter-
face within the Brainvisa image processing software
(http://brainvisa.info/index_f.html) [26]. Input files in-
clude (1) the mouse photograph, (2) the optical surface
scan, (3) a header file containing the position of the
fDOT image relative to the camera's field of view, and
(4) the PET volume image. With this user-friendly
toolbox, three transformation matrices (TfDOT-photo,
Tphoto-PET, and TfDOT-PET) are calculated and sent as
outputs. The program is completed in 20–30 s on a
Dell PrecisionTM T7500 (Dell SA, Montpellier, France)
workstation with a 64-bit IntelW XeonW quad-core pro-
cessor (Intel Corporation, Montpellier SAS, France).
Quantitative evaluation of the co-registration
Fiducial registration error-planar justification
To evaluate quantitatively the performance of our co-
registration method, we calculated the FRE [13,15,16] as
the root mean square (rms) distance of the positions of
the FM in the two image modalities after co-registration
in six independent experiments in six mice. The resulting
FRE values are the mean FRE calculated in four points of
the FM for each mouse. We compared the FRE of our
maximum intensity (MI) method with that of the manual
co-registration (MC) as a reference method and of the
barycenter-based (BC) method [13-18]. The errors were
calculated in the co-registered images with the distance in
pixel unit multiplied by the pixel size of each modality.





Due to the differences of the pixel size in the fDOT image
and the PET image, individual FRE values are calculated
for each modality. Using the BC approach, the FRE was
0.55± 0.11 mm (mean± standard deviation; n=6) and
0.45± 0.08 mm for optical and PET images, respectively.
Using the MI approach, the FRE was 0.26 ± 0.06 mm and
0.25± 0.12 mm for optical and PET images, respectively.
The FRE of the MC approach was 0.28 mm±0.05 mm in
optical images and 0.22± 0.09 mm for PET images. Com-
parison of the three approaches (Table 1) showed that the
MI approach produced average FRE smaller than the BC
approach and in the same range as that of the MC
approach.
In all cases, statistically significant differences were
found between the FRE values of the MI and BC
approaches (student's t test, p= 0.0003 and p= 0.0007 for
optical and PET images, respectively), while no statisti-
cally significant differences were found between the MI
and the MC approach (p= 0.51 and p= 0.55 for optical
and PET images, respectively). Taken together, these
results indicate that the MI approach has the same co-
registration performance with the MC approach and that
both are more precise than the BC approach.
Evaluation of co-registration quality in the z direction
In order to evaluate the co-registration error in the z dir-
ection of our MI approach, the mouse surface image was
fused with the PET image using the transformation matrix
Tphoto-PET. The average error in the z direction was
0.37± 0.06 mm, a value smaller than the voxel size in the z
direction (1 mm in optical images and 0.475 mm in PET
images). Taking into account the error in the z direction,
the 3-D FRE value of our MI approach was 0.452 mm for
the optical image and 0.446 mm for the PET image.
Fiducial localization error and target registration error
The fiducial localization error (FLE) represents the rms
error distance between the estimated and the true posi-
tions of a FM [13,15]. Here, it was calculated following
Fitzpatrick et al. [15]:





Using the average value of the FRE calculated previously
for MI approach (here, N=4), the FLE was 0.35 mm for
the PET images and 0.37 mm for the optical images. The
FLE values were smaller than the 3-D FRE values that are
independent from the fiducial configuration [15].
The target registration error (TRE) is defined as the
distance after co-registration between the corresponding
points in two modalities that not have been used for cal-
culating the co-registration. TRE is derived from the
mean FRE and FLE [15]:
TREh i2 ¼ FLEh i2  FREh i2 ð13Þ
The mean TRE was 0.26 mm for optical images and 0.25
mm for PET image. The calculated TRE was similar as
the FRE for both modalities, indicating that the co-
registration error derived from the FM position and
other positions on the image remain coherent.
Co-registration of tumor vascularity and metabolism
The fDOT-to-PET co-registration method was applied to
six female nude mice bearing xenografts tumor of PC12-
MEN2A cancer cells that mimic a human medullar
Table 1 Fiducial registration errors
FRE MC (mm) MI (mm) BC (mm)
Optical Mean 0.279 0.259 0.545
SD 0.05 0.06 0.11
PET Mean 0.217 0.256 0.448
SD 0.09 0.12 0.08
MC manual co-registration, MI maximal intensity co-registration, BC barycenter-
based co-registration, SD, standard deviation of the mean (n= 6 for all
calculations).
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thyroid carcinoma [20]. The diameter of tumors ranged
from 4.5–8 mm, corresponding to tumor weights of 50–
270 mg. Each mouse received two injections; the first in-
jection was the fluorescent probe SentidyeW, a probe that
passively accumulates in tumors by virtue of the
enhanced permeability and retention effect, and the sec-
ond one is FDG. Each mouse was imaged sequentially
with fDOT and PET.
There was a strong correlation between the volume of
the tumor and the total uptake of FDG, but no correlation
between the tumor volume and the concentration of FDG
in the tumor expressed in percent of injected dose per
cubic centimeter. In other words, the radioactivity concen-
tration remained independent of the tumor volume. The
fDOT signal also increased with tumor size but plateaued
for tumors larger than 150 mg, corresponding to a tumor
with a diameter larger than 6 mm. Again, no correlation
was found between tumor volume and the concentration
of the fDOT signal in the tumor area.
The fDOT-PET fused images (Figure 2) showed the
localization of the optical probe with respect to the glu-
cose consumption of the tumor. After the RODs had
been defined for the mouse holder as indicated above,
fDOT and PET images were co-registered automatically
and the localization of FDG and SentidyeW uptakes were
compared directly. Tumor volumes measured based on
PET-FDG uptake ranged from 53–271 mm3 (mean =
143, SD= 105); tumor volumes measured from fDOT
after SentidyeW uptake ranged from 83–265 mm3
(mean = 170, SD= 86). There was no correlation between
the volumes measured with the two modalities, i.e., the
ratio of fDOT-based to PET-based tumor volumes varied
over almost one order of magnitude (range: 0.35–3.1;
mean = 1.6; SD= 1.0). More interestingly, co-registration
of fDOT with PET showed that the coefficient of overlap
between vascular accumulation of SentidyeW, and tumor
uptake of FDG was 42 ± 14%, indicating that only part of
the tumor was hypervascular while the majority of the
fDOT signal appeared located in the vasculature sur-
rounding the tumor (Figure 2D–F).
Discussion
There is a clear trend towards multi-modal imaging of
tumor as the best way to provide relevant information on
a significant number of cancer hallmarks [1,27]. Recent
studies have demonstrated the possibility to combine
fDOT and PET imaging for co-registered localization of
two or more biological processes at the molecular level
[5,8]. These studies required the use of CT for the ana-
tomical structure, therefore, leading to irradiation of the
animal that has an effect on tumor cell development.
This prompted us to develop direct co-registration of
PET/fDOT without use of CT.
The method for co-registration of PET and fDOT pre-
sented here is based on the detection of the position coor-
dinates of FM visible with both modalities. While
detection of radiolabeled FM with PET is relatively
straightforward, it is not trivial for fDOT since planar op-
tical images do not provide any information on the pos-
ition of the FM in the z axis. Moreover, the acquisition of
3-D fDOT data is slow and would require extremely long
acquisition times to scan a complete volume of the mouse
body. The FM is not contiguous to the mouse body, re-
quiring simultaneous 3-D acquisition for unconnected
objects (i.e., mouse body plus FM), a difficult task to im-
plement. Finally, mice need complete depilation since hair
and fur skew the optical transmission of fluorescent sig-
nals. With these limitations in mind, we developed a
method based on the combination of a planar optical
image with a surface scan of the animal that automatically
determine the full 3-D coordinates of four FM placed
around the body of the animal. Interestingly, the planar
image and the surface scan are acquired in the same refer-
ential as the fDOT volume and, thus, intrinsically co-
registered. After an initialization step to define the regions
in which the FM should be detected (the RODs), this
method allows for automatic detection of the coordinates
of the FM and immediately co-registers the fDOT image
with the PET image. Since the FM are permanently
attached to the animal plate holder, the definition of the
RODs needs to be performed only once for a given animal
supporting plate and remains valid for all following im-
aging sessions with that plate.
The performance of co-registration with the present
automatic method was comparable to that of manual
methods and found to be better than that of the BC ap-
proach, supporting the view that our automatic co-
registration method is at least as accurate as an experi-
enced human observer. The method is based on a simple
principle which is the same as the manual co-
registration, i.e., detection of the points with maximum
intensity, while barycenter approaches use intensity
weighting. However, Wang et al. have reported that co-
registration based on barycenter intensity weighting per-
formed better than an unweighted intensity approach
[13,14]. This apparent discrepancy is likely due to the
shape of the signal from the FM in the PET images. The
FM signal in PET is generally not well-rounded because
of the noise generated by the reconstruction from punc-
tiform sources known as the ‘star’ artifact. This adds ir-
relevant weight to the RODs and renders the detection
of the barycenter largely dependent on the size and
localization of the ROD leading to unpredictable and
often poorly reproducible calculation of the FM's pos-
ition. In contrast, detection by maximal intensity is well
adapted to automatic co-registration and can be general-
ized to any ROD to give reliable co-registered image
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results. As long as the signals from the FM remain above
the surrounding background in the defined regions, the
size and shape of the RODs have no influence on the
results and can be larger or smaller than three times
the diameter of the FM signal size. The aforementioned
evaluation results show the advantages of our method
in terms of reliability and robustness. Moreover, the
method allows the precise and fast co-registration of in-
dividually taken images without any operator-dependent
bias which can be advantageous when a study involves
a large amount of experiments.
Two general solutions are available to compute the
point-based rigid body transformation [R, T] between
the optical and PET coordinates: the iterative method
[28] and the closed form solution method [24,29]. The
closed form solution method is generally superior to the
iterative method in terms of efficiency and robustness
[24]. Eggert et al. have compared four popular algo-
rithms [24], each of which compute the translational and
rotational components of the transform in closed form,
as the solution to a least squares error criterion given by
Equation 3. They found the SVD to give the best results
in terms of 3-D accuracy and stability [24]. This algo-
rithm is, therefore, chosen in the present study.
The proposed co-registration method can easily be
customized for specific applications. The method can
also be applied to co-registration between fDOT and
modalities other than PET, such as CT or MRI, as long
as the images contain the relevant FM. In addition, the
method is adaptable to most fDOT or planar optical im-
aging instruments with surface reconstruction. More-
over, once the RODs have been initialized for a mouse
support with FM, multiple experiments can be co-












Figure 2 Co-registration of fDOT and micro-PET in a mouse bearing a multiple endocrine neoplasis syndrome type 2A tumor
xenograft. Left images are the fusion fDOT/PET image in the sagittal (A), coronal (B) and axial (C) planes. The corresponding zooming images
focus on tumor region the in the sagittal (D), coronal (E) and axial (F) planes. Color scales are ‘temperature’ (dark red to brilliant yellow) for PET
and ‘rainbow’ (blue to white) for fDOT. The white-dotted rectangles point at the reconstruction mesh of the fDOT, while the white arrows
indicate the position of the tumor. Right images are the PET and fDOT signals rendered to the envelope of the mouse corresponding to the
sagittal (G), coronal (H) and axial (I) projections. Pink volume, [18 F]FDG segmented volume inside the tumor; yellow volume, SentidyeW
segmented volume inside the tumor. Both volumes were extracted from the volumes of interests used for the quantification of each type of
signal.
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It is noteworthy that co-registration of fDOT and PET
offers the interesting possibility to co-register and, there-
fore, visualize two purely molecular contrast-based im-
aging methods without the need for referring to another
anatomical imaging method. Where FDG is routinely
used for the staging of tumors, it can be complemented
with fDOT optical images of a second tumor-related ac-
tivity fused to the FDG readouts.
As a proof of concept, we co-registered images of two
well-established hallmarks of cancer: deregulation of glu-
cose consumption through aerobic glycolysis and
increased vascularization through angiogenesis and neo-
vessel formation. Automatic co-registration of glycolysis
with FDG-PET and vascularity with SentidyeW fDOT
clearly demonstrated that the two signals were independ-
ently distributed in multiple endocrine neoplasis syn-
drome type 2A (MEN2A-induced medullary thyroid
carcinoma (MTC) xenografts). MEN2A syndromes are
linked to a mutation of the rearranged during transfection
(RET) proto-oncogene coding for a membrane tyrosine
kinase receptor. The mutation induces constitutive activa-
tion of the RET signaling pathway through dimerization of
RET and is found in families with hereditary MTC and
other disorders [30]. There is evidence that RET constitu-
tively activates angiogenesis, likely through increased
VEGF secretion, in MTC [31], and RET inhibitors induce
inhibition of angiogenesis [32]. The new blood vessels pro-
duced within tumors by chronically activated angiogenesis
(‘angiogenic switch’) are abnormal in their structure, dis-
torted, enlarged, leaky and cause erratic blood flow and
hemorrhagic lakes within the tumor [33]. SentidyeW is a
NIR fluorescence lipidic nano-particle that accumulates
passively in the leaky, abnormal vascular network of
MEN2A-MTC tumors. The observation that it distributes
in a pattern distinct from that of FDG is indicative of the
fact that the tumors are organized into regions with dis-
tinct underlying physiological and molecular characteris-
tics. Assuming that the distribution of the FDG signal
indicates the localization of cancer cells and serves as a
reference to the optical signal [5], it can be concluded that
the hypervascular part of the tumor covers approximately
40 % of the tumor area. The spatial accuracy of both PET
and fDOT reconstructions has been validated with the use
of CT in a previous study [5]. In addition, in a different set
of combined PET/fDOT scans, the tumor area was
sampled after sacrifice of the mice and sectioned for hist-
ology (data not shown). The ex vivo distribution of the
probes matched the in vivo reconstructions perfectly. We,
therefore, conclude that the mismatch in the observed
contrast distribution between fDOT and PET is due to the
nature of the process underlying probe distribution and
not to artifacts in the co-registration method. Interest-
ingly, high FDG uptake which reflects aerobic glycolysis is
not superimposed with high vascularity in MEN2A-MTC
tumors. It would be interesting to explore further the fine
architecture of tumors with other molecular tracers in
order to segment tumoral regions based on, e.g., oxygen
pressure, pH, apoptosis, proliferation or other important
hallmarks of cancer [1]. Alternatively, it could be envi-
sioned to co-register the distribution of a labeled drug or
refine the anatomical information or superimpose maps of
diffusion or viscoelastic properties using other imaging
techniques such as MRI or ultrasound.
In summary, co-registered fDOT-PET is a translational
in vivo molecular imaging modality of simple implementa-
tion that brings relevant information to experimental stud-
ies of tumors. Accurate co-registration combining these
two molecular imaging modalities likely to (1) facilitate
in vitro to in vivo correlations through ex vivo fluorescent
imaging of pathological samples [8], (2) document the
mechanism of uptake of clinically used radiotracers and
contrast agents by adding complementary molecular infor-
mation [8], (3) decipher the changes induced by adminis-
tration of therapy [9], and (4) validate the in vivo targeting
capacity of new molecular probes prior to radioactive la-
beling for PET or SPECT or tagging with paramagnetic
atoms for MRI [8]. Future applications could include the
use of other types of fluorescent probes, in particular,
those that are activated only after interaction with the tar-
get for the monitoring of a variety of tumor-related mole-
cules [8]. Additionally, since optical imaging allows the
imaging of several probes with distinct emission spectra at
the same time, the concept of complementing the FDG
signal with a growing number of information could be fur-
ther extended. The benefits from the fusion of fDOT and
PET in combination with CT are expected to give rise to
scanners where the two modalities are integrated within
the same apparatus, and there are ongoing efforts for the
development of this type of methods [34-36]. The combin-
ation of these two modalities offers new opportunities for
describing tissue physiopathology non-invasively at refined
molecular levels and opens experimental molecular im-
aging to simultaneous detection of multiple molecular tar-
gets and activities (‘multiplexing’).
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